Mark W Hahn is Chief Financial Officer of Verona Pharma plc. Currently has a direct ownership of 14.9 Million shares of VRNA, which is worth approximately $180 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 88,544 shares (Ordinary Shares) at a price of $1.93 per share, resulting in proceeds of $170,889. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.9M
0.59% 3M change
6.47% 12M change
Total Value Held $180 Million

Mark W Hahn Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
SELL
Payment of exercise price or tax liability
$170,889 $1.93 p/Share
88,544 Reduced 0.59%
14,943,032 Ordinary Shares
Feb 01 2024
SELL
Payment of exercise price or tax liability
$1,100,720 $2.29 p/Share
480,664 Reduced 3.1%
15,031,576 Ordinary Shares
Nov 01 2023
SELL
Payment of exercise price or tax liability
$1,407,673 $1.74 p/Share
809,008 Reduced 4.96%
15,512,240 Ordinary Shares
Oct 20 2023
BUY
Grant, award, or other acquisition
-
800,000 Added 4.67%
16,321,248 Ordinary Shares
Aug 07 2023
SELL
Open market or private sale
$21,281 $2.47 p/Share
8,616 Reduced 0.06%
15,521,248 Ordinary Shares
Aug 04 2023
SELL
Open market or private sale
$375,000 $2.5 p/Share
150,000 Reduced 0.96%
15,529,864 Ordinary Shares
Aug 03 2023
SELL
Open market or private sale
$297,870 $2.54 p/Share
117,272 Reduced 0.74%
15,679,864 Ordinary Shares
Aug 02 2023
SELL
Open market or private sale
$190,893 $2.59 p/Share
73,704 Reduced 0.46%
15,797,136 Ordinary Shares
Aug 01 2023
SELL
Open market or private sale
$283,929 $2.68 p/Share
105,944 Reduced 0.66%
15,870,840 Ordinary Shares
May 01 2023
SELL
Open market or private sale
$1,175,262 $2.58 p/Share
455,528 Reduced 2.77%
15,976,784 Ordinary Shares
Feb 01 2023
SELL
Open market or private sale
$1,057,710 $2.56 p/Share
413,168 Reduced 2.45%
16,432,312 Ordinary Shares
Dec 20 2022
SELL
Open market or private sale
$1,272,000 $2.12 p/Share
600,000 Reduced 3.44%
16,845,480 Ordinary Shares
Nov 01 2022
SELL
Payment of exercise price or tax liability
$727,769 $1.6 p/Share
454,856 Reduced 2.54%
17,458,640 Ordinary Shares
Nov 01 2022
SELL
Open market or private sale
$21,977 $1.67 p/Share
13,160 Reduced 0.08%
17,445,480 Ordinary Shares
Sep 26 2022
BUY
Grant, award, or other acquisition
-
3,600,000 Added 16.73%
17,913,496 Ordinary Shares
Aug 09 2022
SELL
Open market or private sale
$1,050,000 $1.75 p/Share
600,000 Reduced 4.02%
14,313,496 Ordinary Shares
Aug 01 2022
SELL
Open market or private sale
$9,218 $0.7 p/Share
13,168 Reduced 0.09%
14,913,496 Ordinary Shares
Aug 01 2022
SELL
Payment of exercise price or tax liability
$304,754 $0.67 p/Share
454,856 Reduced 2.96%
14,926,664 Ordinary Shares
May 03 2022
SELL
Open market or private sale
$6,256 $0.5 p/Share
12,512 Reduced 0.08%
15,381,520 Ordinary Shares
May 01 2022
SELL
Payment of exercise price or tax liability
$224,707 $0.52 p/Share
432,128 Reduced 2.73%
15,394,032 Ordinary Shares
Feb 02 2022
SELL
Open market or private sale
$7,916 $0.76 p/Share
10,416 Reduced 0.07%
15,826,160 Ordinary Shares
Feb 01 2022
SELL
Payment of exercise price or tax liability
$224,890 $0.78 p/Share
288,320 Reduced 1.79%
15,836,576 Ordinary Shares
Feb 01 2022
BUY
Grant, award, or other acquisition
$100,332 $0.75 p/Share
133,776 Added 0.82%
16,124,896 Ordinary Shares
Nov 02 2021
SELL
Open market or private sale
$6,770 $0.65 p/Share
10,416 Reduced 0.07%
15,991,120 Ordinary Shares
Nov 01 2021
SELL
Payment of exercise price or tax liability
$291,103 $0.64 p/Share
454,848 Reduced 2.76%
16,001,536 Ordinary Shares
MWH

Mark W Hahn

Chief Financial Officer
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA